Skip to main content
. 2023 Jan 6;12(1):65–77. doi: 10.21037/tcr-22-1710

Figure 2.

Figure 2

Levels of five biomarkers in the control, adenoma and CRC groups. (A) Levels of mSDC2 in stool. (B) Levels of mSEPT9 in plasma. (C) Serum CEA levels. (D) Serum levels of CA19-9. (E) Serum CA724 levels. ***, P<0.001; **, P<0.01; *, P<0.05. NS., non significant; CRC, colorectal cancer; mSDC2, methylated syndecan2; mSEPT9, methylated septin9; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; CA724, carbohydrate antigen 724.